Beta-adrenergic blocking agents: review and update.
Squire
A
A
Kupersmith
J
J
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007741:Labetalol / Q000494:pharmacology; D050356:Lipid Metabolism; D012995:Solubility
D000319:Adrenergic beta-Antagonists; D007741:Labetalol